Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Eric A. Hughes"'
Autor:
Stacey J. Adam, Timothy G. Buchman, Judith S. Currier, Ruxandra Draghia-Akli, Josh P. Fessel, Elizabeth S. Higgs, Eric A. Hughes, Lisa LaVange, Joseph P. Menetski, Sarah W. Read, Yves Rosenberg, Randall Tressler, ACTIV Therapeutics-Clinical Working Group
Publikováno v:
Journal of Clinical and Translational Science, Vol 8 (2024)
The Accelerating COVID-19 Therapeutic Interventions and Vaccines Therapeutic-Clinical Working Group members gathered critical recommendations in follow-up to lessons learned manuscripts released earlier in the COVID-19 pandemic. Lessons around agent
Externí odkaz:
https://doaj.org/article/a7c8b5fb4a0045bfa8f5cc35ccb6d74c
Publikováno v:
Journal of Clinical and Translational Science, Vol 8 (2024)
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) was an extraordinary example of a public-private partnership (PPP) that brought together over thirty organizations and hundreds of individuals to address one of the most pressing gl
Externí odkaz:
https://doaj.org/article/d2841185b76d4739a38231ca45b74545
Publikováno v:
Ecology and Evolution, Vol 11, Iss 23, Pp 17132-17141 (2021)
Abstract Radio‐frequency identification (RFID) technology has gained popularity in ornithological studies as a way to collect large quantities of data to answer specific biological questions, but few published studies report methodologies used for
Externí odkaz:
https://doaj.org/article/3047f85c328947f38b03739d1a681a7f
Autor:
Lisa M. LaVange, Judith S. Currier, Lora A. Reineck, Eric A Hughes, Sarah W. Read, Elizabeth S. Higgs, Stacey J Adam
Publikováno v:
Annals of Internal Medicine
Despite the development of highly effective SARS-CoV-2 vaccines, there remains a great need for effective treatment of COVID-19. Through a public–private partnership in the United States, a system has been created to efficiently test a variety of t
Autor:
Joseph P. Menetski, Eric A Hughes, Joshua P. Fessel, Stacey J Adam, Timothy G. Buchman, Ruxandra Draghia-Akli, Sarah W. Read, Elizabeth S. Higgs, Neil R. Aggarwal
Publikováno v:
Critical Care Medicine
Supplemental Digital Content is available in the text.
Given the urgent need for coronavirus disease 2019 therapeutics, early in the pandemic the Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines (ACTIV) public-private
Given the urgent need for coronavirus disease 2019 therapeutics, early in the pandemic the Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines (ACTIV) public-private
Publikováno v:
Ecology and Evolution
Ecology and Evolution, Vol 11, Iss 23, Pp 17132-17141 (2021)
Ecology and Evolution, Vol 11, Iss 23, Pp 17132-17141 (2021)
Radio‐frequency identification (RFID) technology has gained popularity in ornithological studies as a way to collect large quantities of data to answer specific biological questions, but few published studies report methodologies used for validatin
Autor:
Barbara, Bartolini, Raffaella, Lionetti, Emanuela, Giombini, Catia, Sias, Chiara, Taibi, Marzia, Montalbano, Gianpiero, D'Offizi, D'Offizi, Gianpiero, Fiona, McPhee, Eric A, Hughes, Nannan, Zhou, Giuseppe, Ippolito, Anna Rosa, Garbuglia, Maria R, Capobianchi
Publikováno v:
Journal of Clinical Virology. 66:38-43
Background Daclatasvir (DCV) is an approved NS5A inhibitor with potent anti-HCV activity and broad genotype coverage. DCV resistance-associated variants (RAVs) have been described for patients infected with genotype (GT) 1, but increased GT4 prevalen
Autor:
T. F. Mc Ewan, C. L. Kuzen, Eric T. Hughes, Edward P. Smith, G. M. Venzor, A. M. Gallagher, Roger W. Graham, Thomas Kostrzewa, W. A. Radford, Michael L. Brest, E. A. Patten
Publikováno v:
physica status solidi c. 7:2522-2525
Raytheon Visions Systems (RVS) is furthering its capability to deliver state-of-the-art high performance large format HgCdTe focal plane arrays (FPAs) for dual-band long-wavelength infrared (LWIR) detection. Missile seekers are designed to acquire ta
Autor:
Markus Zettler, Xiao Tong, Yalan Wang, Christoph Sarrazin, U. Karey, Francisco S. Domingues, Eva Herrmann, Robert Ralston, Eric A. Hughes, Christoph Welsch, Simone Susser, Stefan Zeuzem
Publikováno v:
Hepatology. 50:1709-1718
Boceprevir is a hepatitis C virus (HCV) nonstructural protein (NS) 3/4A protease inhibitor that is currently being evaluated in combination with peginterferon alfa-2b and ribavirin in phase 3 studies. The clinical resistance profile of boceprevir is
Autor:
Jorge E. Galán, Eric A. Hughes
Publikováno v:
Immunity. 16:325-328
Successful immunity against Salmonella infections is dependent on the generation of CD4(+) T helper cells and to a lesser extent on antibody production and CD8(+) T cells. The cells within the lymphatic tissue of the gut are likely to be central for